NCT05442840Active, not recruiting
Evaluation of Pharmacist Intervention for Individuals With Uncontrolled Type 2 Diabetes
Evaluation of Pharmacist Intervention and Education in a Patient-Centered, Multidisciplinary Approach for Individuals With Uncontrolled Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 21 Sept 2026
Brief summary (registry, in English)
Type 2 diabetes is a chronic disease that can lead to a number of complications if uncontrolled and there is a projected increase of 33% patients living with diabetes over the next 10 years. There can be improvements to modifiable risk factors such as diet and exercise, in addition to medications. Treatment often involves a multidisciplinary approach with a physician, endocrinologist, dietitian, pharmacist and other support health professionals as required. This study will evaluate the effects of the pharmacists (or pharmD interns) intervention, looking at changes to the patients HbA1C, which is a measure of the patients blood glucose control over the previous 3 months as well as the patients understanding and comfort with managing their own diabetes via participant survey.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 20 Jun 2022
- Start date
- 4 Jul 2022
- Primary completion date
- Apr 2027
- Lead sponsor
- University of Manitoba
- Diseases
- Type 2 diabetes
- NCT number
- NCT05442840
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 4 Jul 2022 to the primary completion date, Apr 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients whom refuse medication adjustments
- Patients with severe renal impairment or receiving dialysis treatments
Other illness
- Patients with type 1 diabetes, pre-diabetes or gestational diabetes (or whom are pregnant)
Lab values
- Patients with HbA1C less than 10%
Age
- Patients less than 18 years of age
Other
- Patients whom have had recent or ongoing clinical pharmacist directed intervention or intensive health care professional monitoring and guidance
Who the study is looking for
- Patients whose primary care physician is within the Portage Clinic
- Adults (age 18 and older) with type 2 diabetes with HbA1C 10 % or above
- Patients whom have not had previous clinical pharmacist directed intervention
- Agree to participate in the study, including frequent follow up, blood glucose home monitoring as directed and repeat lab work
- Willing to consider medication adjustments as deemed appropriate
- Willing to review and sign the Research Participant Information and Informed Consent Form
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Portage Clinic Coordinator of this site? Confirm its status | Portage la Prairie | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.